Page last updated: 2024-11-07

spironolactone and Anovulation

spironolactone has been researched along with Anovulation in 7 studies

Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.

Anovulation: Suspension or cessation of OVULATION in animals or humans with follicle-containing ovaries (OVARIAN FOLLICLE). Depending on the etiology, OVULATION may be induced with appropriate therapy.

Research Excerpts

ExcerptRelevanceReference
" 51 women completed a 6-month OCP trial (20 µg ethinyl estradiol + 75 µg gestodene, 21/28 days per cycle, plus 100 mg spironolactone in 32 women with moderate to severe hirsutism)."3.78Aromatase gene polymorphism does not influence clinical phenotype and response to oral contraceptive pills in polycystic ovary syndrome women. ( Maier, PS; Spritzer, PM, 2012)
"Acne is an off-label use of some COCs."1.72Female Pelvic Conditions: Polycystic Ovary Syndrome. ( Brady, PH; Gin, GT; Rosenblum, E; Wilkinson, LD, 2022)
"Spironolactone treatment resulted in the improvement or disappearance of acne in 4 of 5 patients who suffered from this ailment."1.27Spironolactone therapy for hyperandrogenic anovulatory women--clinical and endocrinological study. ( Asai, M; Hanai, K; Ichikawa, Y; Kikkawa, H; Masahashi, T; Mizutani, S; Narita, O; Ohsawa, M; Tomoda, Y; Wu, MC, 1986)
"Thirteen anovulatory oligomenorrheic, hyperandrogenic, and normoprolactinemic women were treated with spironolactone (aldactone) throughout six consecutive menstrual cycles in a dosage of 100 to 150 mg/day."1.26Induction of ovulation with spironolactone (Aldactone) in anovulatory oligomenorrheic and hyperandrogenic women. ( Diamant, YZ; Evron, S; Shapiro, G, 1981)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19903 (42.86)18.7374
1990's2 (28.57)18.2507
2000's0 (0.00)29.6817
2010's1 (14.29)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Wilkinson, LD1
Brady, PH1
Gin, GT1
Rosenblum, E1
Maier, PS1
Spritzer, PM1
Evron, S1
Shapiro, G1
Diamant, YZ1
Koloszár, S1
Szöllösi, J1
Bártfai, G1
McKenna, KM1
Pepperell, RJ1
Evans, J1
Bolanowski, M1
Grabiński, M1
Milewicz, A1
Zalewski, J1
Masahashi, T1
Wu, MC1
Ohsawa, M1
Asai, M1
Ichikawa, Y1
Hanai, K1
Kikkawa, H1
Mizutani, S1
Narita, O1
Tomoda, Y1

Trials

2 trials available for spironolactone and Anovulation

ArticleYear
[Ovulation induction with adjuvant antiandrogen treatment in Stein-Leventhal syndrome].
    Orvosi hetilap, 1996, Nov-17, Volume: 137, Issue:46

    Topics: Adult; Androgen Antagonists; Anovulation; Cyproterone Acetate; Dexamethasone; Female; Humans; Hypera

1996
Induction of ovulation by pulsatile LH-RH administration in polycystic ovarian syndrome.
    Endokrynologia Polska, 1989, Volume: 40, Issue:6

    Topics: Anovulation; Drug Therapy, Combination; Female; Gonadotropin-Releasing Hormone; Humans; Infertility,

1989

Other Studies

5 other studies available for spironolactone and Anovulation

ArticleYear
Female Pelvic Conditions: Polycystic Ovary Syndrome.
    FP essentials, 2022, Volume: 515

    Topics: Acne Vulgaris; Anovulation; Female; Finasteride; Gonadotropin-Releasing Hormone; Hirsutism; Humans;

2022
Aromatase gene polymorphism does not influence clinical phenotype and response to oral contraceptive pills in polycystic ovary syndrome women.
    Gynecologic and obstetric investigation, 2012, Volume: 74, Issue:2

    Topics: Adult; Androgens; Anovulation; Aromatase; Blood Pressure; Body Mass Index; Contraceptives, Oral; Eth

2012
Induction of ovulation with spironolactone (Aldactone) in anovulatory oligomenorrheic and hyperandrogenic women.
    Fertility and sterility, 1981, Volume: 36, Issue:4

    Topics: 17-Ketosteroids; Androgens; Anovulation; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Lu

1981
Hirsutism in a gynaecological context.
    The Australian & New Zealand journal of obstetrics & gynaecology, 1990, Volume: 30, Issue:2

    Topics: Adult; Anovulation; Contraceptives, Oral, Hormonal; Female; Gonadal Steroid Hormones; Hirsutism; Hum

1990
Spironolactone therapy for hyperandrogenic anovulatory women--clinical and endocrinological study.
    Nihon Sanka Fujinka Gakkai zasshi, 1986, Volume: 38, Issue:1

    Topics: Adult; Androgens; Anovulation; Estradiol; Female; Humans; Luteinizing Hormone; Menstruation Disturba

1986